California Nanotechnologies Announces Record Q3 and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
California Nanotechnologies Announces Record Q3 and Evaluates Plans to Purchase Large SPS Unit

•Q3 Revenue approximately $260,000 US •Nine month revenue approximately $465,000 US •New COO appointed

LOS ANGELES, Dec. 01, 2016 (GLOBE NEWSWIRE) -- California Nanotechnologies Corp. (TSX VENTURE:CNO) (“Cal Nano” or the “Company”) is pleased to announce record quarterly revenue of approximately $260,000 US for the period of September 1 st , 2016 to November 30 th , 2016, an increase of 81% from the prior period. Revenues for the fiscal year to date are approximately $465,000 US. This is an increase of 41% from the prior period. For the nine month period, 57% of these revenues are in the Spark Plasma Sintering (“SPS”) division, 25% are in the Sports and Recreational division, and 18% are in the Research and Energy division.

In order to best support Cal Nano’s growing base of Fortune 500 customers, while providing additional sustainable long term revenues, the Company is in the final stages of evaluating the purchase of a large SPS sintering and consolidation system. This unique technology will allow the Company to manufacturer near-net shape parts at a diameter eight times larger than its current system and will provide a critical capability to support large production programs as required by the new microchip manufacturing customer and other large high tech component designers and fabricators. “As a cousin to 3D printing, the field of SPS continues to grow rapidly worldwide and this large machine will greatly aid our ability to provide commercial products on a sustainable basis,” stated COO, Eric Eyerman. “Also of particular note, the company is making steady progress on the development of the technology required in the program for the major microchip manufacturer.” 

The Company is proud to announce the promotion of Eric Eyerman to chief operating officer effective December 1st, 2016. Eric is a chemical engineer from Rutgers University in New Jersey.

For further information, please contact: Mr. Mikel Damke, Executive Assistant to the CEO Tel. No. (403) 660-7770, or (888) 660-7770 Email: m.damke@omni-lite.com Website:  www.calnanocorp.com  

For further information, please contact: Mr. David Grant  CEO and Interim CFO Tel. No.  (562) 404-8510 or (800) 577-6664  Fax. No. (562) 926-6913, Email: d.grant@omni-lite.com Website:  www.calnanocorp.com  

Except for historical information contained herein this document contains forward-looking statements. These statements contain known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 21

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Buena Vida y Salud ACO Celebrated for Value-Based Care Innovation

Updated Category News Views 120

Buena Vida y Salud ACO Achieves National Recognition Buena Vida y Salud ACO has garnered significant acclaim as a recipient of the prestigious 2024 NAACOS Excellence Awards. This recognition highlights the organization's successful dedication to value-based care, shaping effective healthcare solutions tailored for patient needs. Leadership and Commitment to...

Continue Reading
SSCP Lager Bidco AB Shares Insights in Quarterly Report

Updated Category News Views 162

SSCP Lager Bidco AB Shares Insights in Quarterly Report Introduction to the Interim Report SSCP Lager Bidco AB (publ) recently released an interim report detailing the developments from April 1 to June 30 of a specific year, highlighting significant milestones and financial performance. Key Highlights of the Interim Report In this latest report, SSCP Lager Bidco AB...

Continue Reading
Important Corrections to ForFarmers N.V. Shareholder Meeting

Updated Category News Views 167

Update on the Resolutions of ForFarmers N.V. Annual General Meeting In a recent communication regarding the resolutions from the Annual General Meeting of Shareholders at ForFarmers N.V., some critical information was initially misstated. This announcement focuses on clarifying these details to ensure transparency and keep our stakeholders well-informed. Corrections to...

Continue Reading
Strong Increase in U.S. House Prices Despite Rising Rates

Updated Category News Views 90

U.S. House Prices Show Remarkable Growth The latest data reveals that U.S. single-family house prices experienced a strong increase in September, presenting challenges for many potential homeowners due to rising costs. This upward trend in the housing market is noteworthy, particularly as mortgage rates have begun to climb. Monthly Price Adjustments According to the...

Continue Reading
Upbeat BidCo Increases Buyout Offer Price for Believe's Shares

Updated Category News Views 208

Upbeat BidCo Raises Its Public Buyout Offer for Believe In an exciting development for investors, Upbeat BidCo has decided to increase its public buyout offer for Believe to 17.20 euros per share. This decision reflects a commitment to maximizing shareholder value while ensuring the future growth of Believe, a prominent digital music company. Significant Premium on the...

Continue Reading